Robotic Pancreaticoduodenectomy Benefits for Pancreatic Cancer Patients
Robotic pancreaticoduodenectomy (RPD) offers similar or superior outcomes compared to open approaches for pancreatic ductal adenocarcinoma (PDAC) treatment. RPD shows reduced blood loss, lower post-operative pain, and shorter hospital stays. Despite similar operative times, RPD yields better oncological results, including margin status and survival rates. With increasing experience, RPD is poised to become the preferred minimally-invasive option for PDAC surgery.
Liver transplantation gave better 5-year survival than liver resection in combined hepatocellular-cholangiocarcinoma, including tumors within UCSF criteria.
Robotic liver resection using a close-to-open forceps technique was associated with no bile leakage and a shorter hospital stay than laparoscopic resection, even though more complex resections were performed in the robotic group.